India to France: Simvastatin Export Trade Route

The India to France Simvastatin corridor is one of India's established pharmaceutical export routes, with 143 shipments documented worth a combined $2.9M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 66% of all export value, reflecting the consolidated nature of India's simvastatin manufacturing sector.

Across 7 active suppliers, the average shipment value stands at $20.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with simvastatin's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 27 days port-to-port. The route has recorded an annual growth rate of 15.4%, placing it at rank #15 among India's top simvastatin export destinations globally.

On the import side, key buyers of Indian simvastatin in France include CSP VIATRIS SANTE AT CSP- LAB,, CSP VIATRIS SANT AT CSP LAB, CSP MYLAN SAS AT CSP LABO 274 and 25 others. CSP VIATRIS SANTE AT CSP- LAB, is the single largest importer with 6 shipments valued at $363.8K USD.

India's simvastatin exports to France are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 37 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 7 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED — together account for 82% of total trade value on this route. The average shipment value of $20.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as ezetimibe/simvastatine mylan 10mg/40mg 9 and ezetimibe/simvastatine mylan 10mg/20mg 9, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CSP VIATRIS SANTE AT CSP- LAB, is the largest importer with 6 shipments worth $363.8K USD — representing 13% of all simvastatin imports from India on this route. A total of 28 buyers are active on this corridor.